Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized, Double Blind Study of Probiotics in Patients With Cervical Cancer in Clinical Stages IIB Undergoing Concurrent Chemotherapy and Radiation Therapy

NCT05736315 is registered in ClinicalTrials.gov with National Institute of Cancerología as lead sponsor.

NCT NCT05736315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05736315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized, Double Blind Study of Probiotics in Patients With Cervical Cancer in Clinical Stages IIB Undergoing Concurrent Chemotherapy and Radiation Therapy
Lead sponsor
National Institute of Cancerología
Phase
Not applicable
Overall status
Completed
Start date
April 25, 2005
Completion date
March 11, 2022
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, stage iib